Bellevue Group AG

Q2 2023 13F Holdings Report, Stock Holdings

Signature - Title
Christoph Eisenring / Stefano Montalbano - Head Legal & Compliance / CFO
Location
Kuesnacht, Switzerland
Holdings as of
June 30, 2023
Value $
$7.01B
Num holdings
156
Date filed
8/14/2023, 12:53 PM
Description
All US holdings of this investor are reported in this report.
Previous filing
Q1 2023 - May 15, 2023
Sym Weight Trade Impact Company Class Shares Change Activity Value Change $ Value $ * Price $ Shares Principal
Filing 2023 Q2 compared to 2023 Q1 by default.
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.

Person Signing this Report on Behalf of Reporting Manager:

Name Title City, State Date
Christoph Eisenring / Stefano Montalbano Head Legal & Compliance / Signing Authority Kuesnacht, Switzerland 8/14/2023

Other Included Managers (3):

Num Name File Number
1 BB Biotech AG 028-06964
2 Bellevue Asset Management AG 028-16892
3 Bellevue Asset Management (UK) Ltd. 028-20408